These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17367501)

  • 21. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases.
    Rondon IJ; Marasco WA
    Annu Rev Microbiol; 1997; 51():257-83. PubMed ID: 9343351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ER intrabody-mediated inhibition of interferon α secretion by mouse macrophages and dendritic cells.
    Büssow K; Themann P; Luu S; Pentrowski P; Harting C; Majewski M; Vollmer V; Köster M; Grashoff M; Zawatzky R; Van den Heuvel J; Kröger A; Böldicke T
    PLoS One; 2019; 14(4):e0215062. PubMed ID: 30990863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular antibodies as specific reagents for functional ablation: future therapeutic molecules.
    Lobato MN; Rabbitts TH
    Curr Mol Med; 2004 Aug; 4(5):519-28. PubMed ID: 15267223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-WASP intrabodies inhibit inflammatory responses induced by Toll-like receptors 3, 7, and 9, in macrophages.
    Sakuma C; Sato M; Oshima T; Takenouchi T; Chiba J; Kitani H
    Biochem Biophys Res Commun; 2015 Feb; 458(1):28-33. PubMed ID: 25634698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetically encoded intrabodies as high-precision tools to visualize and manipulate neuronal function.
    Trimmer JS
    Semin Cell Dev Biol; 2022 Jun; 126():117-124. PubMed ID: 34782184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrabody-based approaches to cancer therapy: status and prospects.
    Williams BR; Zhu Z
    Curr Med Chem; 2006; 13(12):1473-80. PubMed ID: 16719789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription.
    Mukhtar MM; Li S; Li W; Wan T; Mu Y; Wei W; Kang L; Rasool ST; Xiao Y; Zhu Y; Wu J
    Int J Biochem Cell Biol; 2009 Mar; 41(3):554-60. PubMed ID: 18687409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules.
    Selby M; Erickson A; Dong C; Cooper S; Parham P; Houghton M; Walker CM
    J Immunol; 1999 Jan; 162(2):669-76. PubMed ID: 9916684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the Post-translational Proteome with Intrabodies.
    Cattaneo A; Chirichella M
    Trends Biotechnol; 2019 Jun; 37(6):578-591. PubMed ID: 30577991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The intracellular antibody capture technology: towards the high-throughput selection of functional intracellular antibodies for target validation.
    Visintin M; Quondam M; Cattaneo A
    Methods; 2004 Oct; 34(2):200-14. PubMed ID: 15312673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional inactivation of the conserved Sem1p in yeast by intrabodies.
    Reinman M; Jäntti J; Alfthan K; Keränen S; Söderlund H; Takkinen K
    Yeast; 2003 Sep; 20(12):1071-84. PubMed ID: 12961755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular antibodies and challenges facing their use as therapeutic agents.
    Lobato MN; Rabbitts TH
    Trends Mol Med; 2003 Sep; 9(9):390-6. PubMed ID: 13129705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC class I manipulation on cell surfaces by gene transfer of anti-MHC class I intrabodies--a tool for decreased immunogenicity of allogeneic tissue and cell transplants.
    Busch A; Marasco WA; Doebis C; Volk HD; Seifert M
    Methods; 2004 Oct; 34(2):240-9. PubMed ID: 15312677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoplasmic expression and specific binding of the VH/VL single domain intrabodies in transfected NIH3T3 cells.
    Sawahata R; Sato M; Kitani H
    Exp Mol Pathol; 2009 Feb; 86(1):51-6. PubMed ID: 19094983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein i: interference at protein level by intrabodies.
    Manikandan J; Pushparaj PN; Melendez AJ
    Front Biosci; 2007 Jan; 12():1344-52. PubMed ID: 17127386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones.
    Kim PS; Arvan P
    Endocr Rev; 1998 Apr; 19(2):173-202. PubMed ID: 9570036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
    John A; Kizhakkedath P; Al-Gazali L; Ali BR
    Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection and use of intracellular antibodies (intrabodies).
    Moutel S; Nizak C; Perez F
    Methods Mol Biol; 2012; 907():667-79. PubMed ID: 22907379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrabodies as drug discovery tools and therapeutics.
    Stocks M
    Curr Opin Chem Biol; 2005 Aug; 9(4):359-65. PubMed ID: 15979379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.